Study on the effect of polybutyl-2-cyanoacrylate nanoparticles and their metabolites on the phagocytic activity of peritoneal exudate cells of mice

Biomaterials

Volumn 24, Issue 2, 2003, Pages 313-320

  Simeonova, M ^a   Antcheva, M ^b   Chorbadjiev, K ^c  

^a INSTITUTE OF POLYMERS   (Bulgaria)

^b National Oncology Center Bulgaria   (Bulgaria)

^c Sci Res Ctr of Specialty Polymers   (Bulgaria)

Author keywords

Ingestion capacity; n Butanol; Peritoneal exudate cells (PECs); Phagocytic activity; Phagocytic index; Phagocytic number; Poly(alkylcyanoacrylates); Poly(butylcyanoacrylate) nanoparticles; Poly(cyanoacrylic acid); SRBC

Indexed keywords

BIOASSAY; CELLS; METABOLITES; ORGANIC POLYMERS;

NANOPARTICLES;

BIOMATERIALS;

ACRYLIC ACID DERIVATIVE; BUTANOL; CYANOACRYLATE DERIVATIVE; NANOPARTICLE; POLYBUTYL 2 CYANOACRYLATE; POLYMER; UNCLASSIFIED DRUG; ENBUCRILATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; ERYTHROCYTE COUNT; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM CELL; PERITONEUM EXUDATE; PHAGOCYTOSIS; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; SUSPENSION; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; NANOTECHNOLOGY; PARTICLE SIZE;

OVIS ARIES;

ANIMALS; ENBUCRILATE; MALE; MICE; MICE, INBRED C57BL; NANOTECHNOLOGY; PARTICLE SIZE; PERITONEAL CAVITY; PHAGOCYTOSIS;

EID: 0037209976     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00321-6     Document Type: Article

References (41)

1. Birrenbach G., Speiser P. Polymerized micelles and their use as adjuvants in immunology. J Pharm Sci. 65:1976;1763-1766.
2. Kreuter J., Speiser P. In vitro studies of poly(methyl methacrylate) adjuvants. J Pharm Sci. 65:1976;1624-1627.
3. Couvreur P, Roland M, Speiser P. Biodegradable submicroscopic particles containing a biologically active substance and composition containing them. U.S. Patent 4,329,332,1982.
4. Couvreur P., Kante B., Roland M., Guiot P., Baudhuin P., Speiser P. Poly(alkylcyanoacrylate) nanocapsules as potential lysosomotropic carriers. preparation, morphological and sorptive properties J Pharm Pharmacol. 31:1979;331-332.
5. Fattal E., Vauthier C., Aynie I., Nakada Y., Lambert G., Malvy C., Couvreur P. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J Control Release. 53:1998;137-143.
6. Couvreur P. Polyalkylcyanoacrylates as colloidal drug carriers. CRC Crit Rev Ther Drug Carrier Systems. 5:1988;1-20.
7. O'Hagan D.T., Palin K., Davis S.S. Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization. Vaccine. 7:1989;213-216.
8. Dundarov S, Kawaklova L, Markova R, Tateosyan D, Valkova B, Simeonova M, Lossev B, Petrova M. Clinical and immunological effectiveness of different types of herpes vaccines produced in Bulgaria. Proceedings of the eighth International Congress on Infectious Diseases, 1998.
9. Assenova B, Karparov A, Simeonova M. A new pathway of activation of the Epstein-Barr virus productive cycle. Proceedings of the 10th Balkan Biochem Biophys Days, 1994. p. 416-7.
10. Couvreur P., Roblot-Treupel L., Poupon M., Brasseur F., Puisieux F. Microparticles as microcarriers for anticancer drugs. Adv Drug Delivery Rev. 5:1990;209-230.
11. Grangier J.L., Puygrenier M., Gauthier J.C., Couvreur P. Nanoparticles as carriers for growth hormone realizing factors (GRF). J Control Release. 15:1991;3-13.
12. Gautier J.C., Grangier J.L., Barbier A., Dupont P., Dussossoy D., Pastor G., Couvreur P. Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF). J Control Release. 20:1992;67-78.
13. Gaspar R., Opperdoes F.R., Preat V., Roland M. Drug targeting with polyalkylcyanoacrylate nanoparticles. in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani Ann Trop Med Parasitol. 86:1992;41-49.
14. Couvreur P., Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv Drug Delivery Rev. 10:1993;141-162.
15. Chiannilkulchai N., Driouich Z., Benoit J.P., Parody A.L., Couvreur P. Doxorubicin-loaded nanoparticles. increased efficiency in murine hepatic metastases Select Cancer Ther. 5:1989;1-11.
16. Cuvier C., Roblot-Treupel L., Millot J.M., Lizard G., Chevillard S., Manfait M., Couvreur P., Poupon M.F. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol. 44:1992;509-517.
17. Henry-Micheland M.J., Alonso M.J., Andermont A., Maincient P., Sauziers J., Couvreur P. Attachment of antibiotics to nanoparticles. preparation, drug-release and antimicrobial activity in vitro Int J Pharm. 35:1987;121-127.
18. Damgé C., Michel C., Aprahamian M., Couvreur P., Devissague J.P. Nanocapsules as carriers for oral peptide delivery. J Controlled Release. 13:1990;233-239.
19. Grislain L., Couvreur P., Lenaerts V., Roland M., Deprez-Decampeneere D., Speiser P. Pharmacokinetics and distribution of a biodegradable drug-carrier. Int J Pharm. 15:1983;335-345.
20. Lenaerts V., Nagelkerke J.F., Van Berkel T.J.C., Couvreur P., Grislain L., Roland M., Speiser P. In vivo uptake of polyisobutylcyanoacrylate nanoparticles by rat liver, Kupffer, endothelial and parenchymal cells. J Pharm Sci. 73:1984;980-983.
21. Gibaud S., Demoy M., Andreux J.P., Weingarten C., Gouritin B., Couvreur P. Cells involved in the capture of nanoparticles in hematopoietic organs. J Pharm Sci. 85:1996;944-950.
22. Guiot P., Couvreur P. Quantitative study of the interaction between polybutylcyanoacrylate nanoparticles and mouse peritoneal macrophage in culture. J Pharm Belg. 38:1983;397-405.
23. Schäfer V., von Briesen H., Rübsamen-Waigmann H., Steffan A., Royer C., Kreuter J. Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages. J Microencapsulation. 11:1994;261-269.
24. Rolland A., Merdrignac G., Gouranton J., Bourel D., Le Verge R., Genetet B. Flow cytometric quantitative evaluation of phagocytosis by human mononuclear and polymorphonuclear cells using fluorescent nanoparticles. J Immunol Methods. 96:1987;185-193.
25. Fernández-Urrusuno R., Fattal E., Rodrigues J.M., Féger J., Bedossa P., Couvreur P. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice. J Biomed Mater Res. 31:1996;401-408.
26. Peracchia M.T., Vauthier C., Passirani C., Couvreur P., Labarre D. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci. 61:1997;749-761.
27. Leroux JC, Gravel P, Balant L, Volet Bernard, Anner BM, Allémann E, Doelker E, Gurny R. Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles. J Biomed Mater Res 1994;28:471-81.
28. van Oss C.F., Gillman C.F., Neumann A.W. Phagocytic engulfment and cell adhesiveness as cellular surface phenomena. 1975;Marcel Dekker, New York.
29. Maincent P., Thouvenot P., Amicabile C., Hoffman M., Kreuter J., Couvreur P., Devissaguet J.P. Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharm Res. 9:1992;1534-1539.
30. Lenaerts V., Couvreur P., Christians-Leyh D., Joiris E., Rolland M., Rollman B., Speiser P. Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials. 5:1984;65-68.
31. Lyeh D., Couvreur P., Lenaerts V., Roland M., Speiser P. Etude du mechanisme de degradation des nanoparticules de polycyanoacrylate d'alkyl. Labo-Pharma - Probl Tech. 32:1984;100-104.
32. Scherer D., Robinson J.R., Kreuter J. Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles. Int J Pharm. 101:1994;303-307.
33. Simeonova M., Chorbadjiev K., Antcheva M. Study of the effect of polybutylcyanoacrylate nanoparticles and their metabolites on the primary immune response in mice to sheep red blood cells. Biomaterials. 19:1998;2187-2193.
34. Rudt S., Müller R.H. In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration. J Controlled Release. 22:1992;263-272.
35. Schäfer V., von Briesen H., Andreesen R., Steffan A., Royer C., Tröster S., Kreuter J., Rübsamen-Waigmann H. Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages. a possibility for antiviral drug targeting Pharm Res. 9:1992;541-546.
36. Cruz T., Gaspar R., Donato A., Lopes C. Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages. MTT metabolism, NBT reduction, and no production Pharm Res. 14:1997;73-79.
37. Basista M.H., Bavaler J., Stieffenhofer A., Love E., Rosenblum E., Dindzans V.J. Effect of ethanol on Kupffer cell function. Alcohol Clin Exp Res. 17:1993;556-560.
38. Artursson P., Arro E., Edman P., Ericsson J.L.E., Sjöholm I. Biodegradable microspheres V. stimulation of macrophages with microparticles made of various polysaccharides J Pharm Sci. 76:1987;127-133.
39. Kanke M., Geissler R.G., Powell D., Kaplan A., DeLuca P.P. Interaction of microspheres with blood constituents III. Macrophage phagocytosis of various types of polymeric carriers. J Parent Sci Technol. 42:1988;157-165.
40. Gaspar R., Preat V., Opperdoes R.R., Roland M. Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates. activity against intracellular Leishmania donovani associated with hydrogen peroxide production Pharm Res. 9:1992;782-787.
41. Ellens H., Mayhew E., Rustum Y.M. Reversible depression of the reticuloendothelial system by liposomes. Biochim Biophys Acta. 714:1982;479-485.